Author:
Nizard Philippe,Ezan Frédéric,Bonnier Dominique,Le Meur Nolwenn,Langouët Sophie,Baffet Georges,Arlot-Bonnemains Yannick,Théret Nathalie
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Sharma SV, Bell DW, Settleman J, Haber DA: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer. 2007, 7: 169-181. 10.1038/nrc2088.
2. Quintás-Cardama A, Kantarjian H, Abruzzo LV, Cortes J: Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy. Leukemia. 2007, 21: 2394-2396. 10.1038/sj.leu.2404865.
3. Hynes NE, Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005, 5: 341-354. 10.1038/nrc1609.
4. Garrett MD, Walton MI, McDonald E, Judson I, Workman P: The contemporary drug development process: advances and challenges in preclinical and clinical development. Prog Cell Cycle Res. 2003, 5: 145-158.
5. Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, Hinkle G, Boehm JS, Beroukhim R, Weir BA, Mermel C, Barbie DA, Awad T, Zhou X, Nguyen T, Piqani B, Li C, Golub TR, Meyerson M, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE: Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A. 2008, 105: 20380-5. 10.1073/pnas.0810485105.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献